CFTX-1554 is under clinical development by Eli Lilly and Co and currently in Phase I for Peripheral Neuropathic Pain.

ANP-390 is under clinical development by AlphaNavi Pharma and currently in Phase I for Peripheral Neuropathic Pain.

Although systematic reviews have outlined the current treatment options for neuropathic ... but NNTs were calculated for many peripheral neuropathic pain conditions. The NNT for tricyclic ...

Peripheral artery disease is the narrowing and blocking of the arteries in the legs. This process of furring up of the blood ...

Neuropathic pain syndrome is a challenge to treat and, even with appropriate evidence-based treatment, only a 40% reduction of symptoms can be achieved in approximately half of patients.

Diabetic Foot Disease is defined as a syndrome in which peripheral neuropathy and peripheral vascular disease may result in foot ...

Peripheral nerves are the conduit for sensory information to the central nervous system. Peripheral sensory neurons are unique in spanning vast anatomical regions, linking the spinal cord to the ...

Objective: To study the role of mechanical, infectious, and inflammatory factors inducing neuropathic attacks in hereditary brachial plexus neuropathy (HBPN), an autosomal dominant disorder ...

“Our report indicates that the nerve entrapment syndrome therapeutics industry will continue to grow robustly, propelled by the urgent need for effective treatments.” The report also highlights ...

Some people have labeled glaucoma as the quiet disease, until it steals your vision, and then there are symptoms. In this ...

Imagine putting your socks on one morning and noticing your big toe, which has been painful for a few weeks, has started turning black. A trip to your ...

Compared with placebo, treatment with sotagliflozin led to similar reductions in A1C ... Lexicon is continuing the phase 2b ...